Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18,273,150 | $21,308,844 | $22,499,553 | $22,376,928 |
| Short-Term Investments | $10,196,365 | $4,000 | $56,873 | $0 |
| Receivables | $20,449,402 | $19,597,697 | $20,084,953 | $18,389,215 |
| Inventory | $12,811,902 | $11,507,100 | $10,671,573 | $10,437,734 |
| Other Curr. Assets | $1,203,611 | $2,836,916 | $2,551,590 | $2,785,413 |
| Total Curr. Assets | $57,762,228 | $55,983,714 | $57,064,312 | $52,810,574 |
| Property Plant & Equip (Net) | $7,937,612 | $7,513,872 | $6,567,669 | $5,681,523 |
| Goodwill | $830,855 | $829,473 | $829,473 | $829,473 |
| Intangibles | $3,198,697 | $3,196,307 | $2,825,766 | $2,592,958 |
| Long-Term Investments | $0 | $9,621,536 | $5,840,078 | $3,240,548 |
| Tax Assets | $1,210,404 | $1,163,548 | $865,339 | $794,232 |
| Other NC Assets | $10,743,816 | $278,428 | $672,661 | $168,481 |
| Total NC Assets | $23,921,383 | $22,603,164 | $17,600,987 | $13,307,215 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $81,683,612 | $78,586,878 | $74,665,299 | $66,117,790 |
| Liabilities | – | – | – | – |
| Payables | $16,319,521 | $15,685,868 | $8,740,910 | $14,732,969 |
| Short-Term Debt | $9,122,982 | $7,799,036 | $9,644,939 | $8,428,008 |
| Tax Payable | $248,911 | $249,264 | $375,711 | $233,497 |
| Deferred Revenue | $0 | $0 | $5,644,202 | $8,501,011 |
| Other Curr. Liab. | $7,250,862 | $6,375,594 | $11,783,680 | $6,352,536 |
| Total Curr. Liab. | $38,915,689 | $36,235,291 | $37,395,116 | $32,253,851 |
| LT Debt | $2,805,539 | $3,323,718 | $1,639,203 | $752,812 |
| Deferred Rev, NC | $1,001,862 | $0 | $930,926 | $826,859 |
| Deferred Tax Liab, NC | $625,557 | $639,529 | $394,588 | $331,728 |
| Other NC Liab. | $119,613 | $1,132,324 | $121,764 | $128,173 |
| Total NC Liab. | $4,998,286 | $5,673,763 | $3,632,325 | $2,537,270 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $445,715 | $578,192 | $545,843 | $497,698 |
| Total Liabilities | $43,913,976 | $41,909,054 | $41,027,441 | $34,791,121 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,625,791 | $1,625,791 | $1,625,791 | $1,625,791 |
| Retained Earnings | $21,815,337 | $20,959,331 | $18,262,133 | $15,588,203 |
| AOCI | -$13,840 | -$24,344 | -$12,901 | -$17,476 |
| Other Equity | $3,407,123 | $3,310,234 | $3,141,832 | $2,817,397 |
| Total Equity | $35,904,528 | $34,919,281 | $32,065,125 | $29,062,184 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,865,108 | $1,758,543 | $1,572,733 | $2,264,484 |
| Total Liab. & Tot. Equity | $81,683,612 | $78,586,878 | $74,665,299 | $66,117,790 |
| Net Debt | -$6,344,629 | -$10,186,091 | -$11,215,411 | -$13,196,107 |